Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab

Premium

Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.

Omics-Driven Drug Discovery Firm Octant Raises $30M in Series A Financing Round

Silicon Valley venture capital firm Andreessen Horowitz led the round, joined by 8VC, SV Angel, Allen & Co, and several other undisclosed private investors.

Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19

Premium

The diagnostics firm is conducting a 1,000-person study to find T cell profiles associated with the immune response to COVID-19 and recovery from the disease.

Twist Bioscience Q2 Revenues Increase 42 Percent

The synthetic biology firm had total revenues of $19.3 million and withdrew its financial guidance for fiscal year 2020 citing uncertainty caused by COVID-19.

Mount Sinai Researchers Mine Literature, Social Media for COVID-19 Gene and Drug Resource

Premium

Mount Sinai bioinformaticians have quickly pivoted from Lyme disease research to building a reference tool for researchers pursuing COVID therapies.

Apr 30, 2020

COVID-19 Proteomics Study Identifies Existing Compounds as Potential Antivirals

Apr 27, 2020

Rockefeller University, Cerevance Pursue Pooled Nuclei Sequencing to Target Brain Cell Types

Premium

Apr 23, 2020

Harvard Spinout 1CellBio Seeks Ideas for Applications of Targeted Single-Cell Tech

Premium

Apr 21, 2020

Envisagenics to Bring RNA Splicing Software Platform to J&J Lung Cancer Initiative

Apr 15, 2020

Axovant, Invitae Launch Free Genetic Testing Program for Lysosomal Storage Diseases

Apr 14, 2020

African Genomics Company 54gene Closes $15M Series A Round

Apr 06, 2020

Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery

Apr 02, 2020

ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam

Mar 27, 2020

10x Genomics Joins Single-Cell Multi-Omics Alliance to Develop Antibody Therapies for Coronavirus

Mar 26, 2020

GigaMune Hopes to Offer TCR Screens to Pharmas While Scrambling to Keep Expression Libraries Alive

Premium

Mar 09, 2020

Invicro, Yale Partner to Advance Biomarker Detection Tech

Mar 06, 2020

PMI Biopharma, Nashville Biosciences Form Drug Development Services Alliance

Feb 27, 2020

ZPredicta, LabCorp Form Cancer Cell Culture Model Partnership

Feb 21, 2020

Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes

Premium

Feb 20, 2020

FDA Releases List of Evidence-Based PGx Variants

Feb 11, 2020

Advaxis Taps Personalis for Biomarker Discovery in Lung Cancer Immunotherapy Program

Feb 04, 2020

Cellectricon, StressMarq Ink Neurodegenerative Disease Research Deal

Feb 03, 2020

ImiDomics, Gossamer Bio Form Immune-Mediated Inflammatory Disease Alliance

Jan 24, 2020

Predictive Oncology to Acquire Quantitative Medicine

Jan 23, 2020

Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Featured White Papers

Normal Isolated Immune Cells: Custom Sourcing for a 30 Patient, Matched Monocytes and Pan T-cells Study

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Multi-Parameter Epitope-Centric Data Used to Elucidate Mechanisms of Action of Antibodies

Generating High Quality Kinetic Data from Crude Periplasmic Extracts Using High Throughput SPR

Jun

02

Featured Webinar

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics.

Jul

15

Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Menu

Drug Discovery & Development